ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/19 | 1,870 | 1,960 | 1,834 | 1,856 | +6 | +0.3% | 1,513,600 |
| 2024/08/16 | 1,795 | 1,852 | 1,757 | 1,850 | +95 | +5.4% | 1,641,800 |
| 2024/08/15 | 1,859 | 1,870 | 1,672 | 1,755 | -176 | -9.1% | 3,659,900 |
| 2024/08/14 | 1,861 | 1,948 | 1,853 | 1,931 | +50 | +2.7% | 1,139,200 |
| 2024/08/13 | 1,868 | 1,905 | 1,833 | 1,881 | +43 | +2.3% | 867,100 |
| 2024/08/09 | 1,877 | 1,910 | 1,786 | 1,838 | -3 | -0.2% | 1,260,500 |
| 2024/08/08 | 1,719 | 1,869 | 1,716 | 1,841 | +109 | +6.3% | 1,393,900 |
| 2024/08/07 | 1,602 | 1,788 | 1,570 | 1,732 | +90 | +5.5% | 1,675,800 |
| 2024/08/06 | 1,640 | 1,695 | 1,537 | 1,642 | +98 | +6.3% | 2,702,900 |
| 2024/08/05 | 1,717 | 1,728 | 1,544 | 1,544 | -400 | -20.6% | 2,990,800 |
| 2024/08/02 | 2,133 | 2,158 | 1,941 | 1,944 | -271 | -12.2% | 1,962,800 |
| 2024/08/01 | 2,260 | 2,287 | 2,205 | 2,215 | -79 | -3.4% | 685,300 |
| 2024/07/31 | 2,342 | 2,361 | 2,267 | 2,294 | -98 | -4.1% | 806,900 |
| 2024/07/30 | 2,410 | 2,429 | 2,321 | 2,392 | -18 | -0.7% | 645,500 |
| 2024/07/29 | 2,310 | 2,410 | 2,310 | 2,410 | +130 | +5.7% | 587,900 |
| 2024/07/26 | 2,214 | 2,321 | 2,214 | 2,280 | +73 | +3.3% | 741,600 |
| 2024/07/25 | 2,191 | 2,249 | 2,180 | 2,207 | -26 | -1.2% | 654,100 |
| 2024/07/24 | 2,272 | 2,332 | 2,232 | 2,233 | -53 | -2.3% | 666,300 |
| 2024/07/23 | 2,295 | 2,314 | 2,218 | 2,286 | +8 | +0.4% | 889,100 |
| 2024/07/22 | 2,410 | 2,424 | 2,273 | 2,278 | -157 | -6.4% | 1,289,000 |
| 2024/07/19 | 2,571 | 2,594 | 2,433 | 2,435 | -156 | -6% | 1,065,600 |
| 2024/07/18 | 2,665 | 2,710 | 2,510 | 2,591 | -92 | -3.4% | 1,823,600 |
| 2024/07/17 | 2,633 | 2,703 | 2,623 | 2,683 | +125 | +4.9% | 1,011,900 |
| 2024/07/16 | 2,584 | 2,609 | 2,555 | 2,558 | +21 | +0.8% | 773,300 |
| 2024/07/12 | 2,441 | 2,554 | 2,438 | 2,537 | +96 | +3.9% | 848,700 |
| 2024/07/11 | 2,450 | 2,475 | 2,430 | 2,441 | +16 | +0.7% | 492,200 |
| 2024/07/10 | 2,454 | 2,457 | 2,365 | 2,425 | -21 | -0.9% | 667,900 |
| 2024/07/09 | 2,470 | 2,507 | 2,431 | 2,446 | -20 | -0.8% | 746,700 |
| 2024/07/08 | 2,464 | 2,468 | 2,397 | 2,466 | +30 | +1.2% | 460,300 |
| 2024/07/05 | 2,385 | 2,453 | 2,348 | 2,436 | +57 | +2.4% | 648,800 |
| 2024/07/04 | 2,351 | 2,408 | 2,339 | 2,379 | +37 | +1.6% | 501,900 |
| 2024/07/03 | 2,290 | 2,342 | 2,282 | 2,342 | +55 | +2.4% | 496,200 |
| 2024/07/02 | 2,350 | 2,369 | 2,279 | 2,287 | -53 | -2.3% | 751,600 |
| 2024/07/01 | 2,419 | 2,438 | 2,340 | 2,340 | -29 | -1.2% | 1,046,800 |
| 2024/06/28 | 2,450 | 2,450 | 2,352 | 2,369 | -81 | -3.3% | 787,000 |
| 2024/06/27 | 2,325 | 2,525 | 2,325 | 2,450 | +125 | +5.4% | 1,511,800 |
| 2024/06/26 | 2,371 | 2,371 | 2,303 | 2,325 | -50 | -2.1% | 609,300 |
| 2024/06/25 | 2,365 | 2,403 | 2,336 | 2,375 | +22 | +0.9% | 606,500 |
| 2024/06/24 | 2,431 | 2,466 | 2,353 | 2,353 | -107 | -4.3% | 902,900 |
| 2024/06/21 | 2,458 | 2,506 | 2,446 | 2,460 | +3 | +0.1% | 936,700 |
| 2024/06/20 | 2,350 | 2,457 | 2,346 | 2,457 | +131 | +5.6% | 1,118,000 |
| 2024/06/19 | 2,303 | 2,335 | 2,265 | 2,326 | +16 | +0.7% | 570,000 |
| 2024/06/18 | 2,376 | 2,395 | 2,305 | 2,310 | -65 | -2.7% | 943,000 |
| 2024/06/17 | 2,290 | 2,376 | 2,283 | 2,375 | +85 | +3.7% | 930,800 |
| 2024/06/14 | 2,173 | 2,323 | 2,173 | 2,290 | +67 | +3% | 768,600 |
| 2024/06/13 | 2,262 | 2,335 | 2,223 | 2,223 | -24 | -1.1% | 894,200 |
| 2024/06/12 | 2,257 | 2,283 | 2,230 | 2,247 | -6 | -0.3% | 394,100 |
| 2024/06/11 | 2,216 | 2,277 | 2,211 | 2,253 | +69 | +3.2% | 886,200 |
| 2024/06/10 | 2,158 | 2,185 | 2,115 | 2,184 | +12 | +0.6% | 618,000 |
| 2024/06/07 | 2,094 | 2,172 | 2,093 | 2,172 | +68 | +3.2% | 352,800 |
151～
200
件表示中 / 3671件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 193,800円 | +21.7% | +999.9% | 0.00% | 8.07倍 | 2.67倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 170,000円 | - | - | 0.00% | - | 78.74倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 持田薬 | 310,000円 | +3.0% | +27.5% | 2.58% | 19.63倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 145,500円 | +3.2% | +4.5% | 3.57% | 16.72倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 221,100円 | +0.4% | -8.4% | 2.40% | 28.39倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
